Literature DB >> 6450001

Circulating platelet products in unstable angina pectoris.

M Sobel, E W Salzman, G C Davies, R I Handin, J Sweeney, J Ploetz, G Kurland.   

Abstract

In 19 patients with unstable angina pectoris at rest, plasma levels of the platelet-derived proteins beta-thromboglobulin and platelet factor 4 were significantly elevated in blood samples obtained during or within 4 hours after episodes of angina, but were usually normal during quiescent intervals. Plasma levels of the arachidonic acid metabolite thromboxane B2 were less clearly related to angina, and there was no association of angina with levels of the coagulation product fibrinopeptide A. This demonstration of an association of platelet activation and secretion with unstable angina pectoris by radioimmunoassay of circulating platelet constituents offers a new approach to assessment of therapy in ischemic heart disease and suggests that agents that alter platelet function should be evaluated in patients with unstable angina.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450001     DOI: 10.1161/01.cir.63.2.300

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Evaluation of platelet function in aspirin treated patients with CAD.

Authors:  Marlene S Williams; Thomas S Kickler; Dhananjay Vaidya; Ladina S Ng'alla; David E Bush
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

2.  Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.

Authors:  P S Kiff; G Bergman; L Atkinson; D E Jewitt; J Westwick; V V Kakkar
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.

Authors:  A M Grauholt; P Grande; J Wadt
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Calcium antagonists. Clinical use in the treatment of angina.

Authors:  P Théroux; Y Taeymans; D D Waters
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.

Authors:  U Schmitz-Huebner; S G Thompson; L Balleisen; C Fechtrup; W Grosse-Heitmeyer; B Kirchhof; E Most; U S Müller; C Seiffert; D Seiffert
Journal:  Br Heart J       Date:  1988-03

6.  Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease.

Authors:  M H Kim; S H Huo; K S Kim; M S Kim; J S Song
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.